Partnering for Progress: How Your Family Can Drive GRI Research with Simons Searchlight

Share This Post

Did you know that CureGRIN is partnered with Simons Searchlight to help advance research on GRI Disorders? Since 2010, Simons Searchlight has been our trusted research partner focused on understanding rare genetic neurodevelopmental disorders, including autism, seizures, and developmental delays, by collecting valuable data from families like yours.

Why Participate in Simons Searchlight?

  1. Comprehensive Data & Blood Sample Collection: Through online surveys (e.g. Annual Medical History, Vineland, Seizure History, Child Behavior Checklist, etc.) and optional blood samples, Simons Searchlight gathers crucial information on genetics, development, behavior, and more. Donated blood is used to make research resources, including cell lines, DNA samples, and selected induced pluripotent stem cells or iPSCs. This combined data forms a powerful toolkit for researchers.
  2. Expert Support: Participants have access to Simons Searchlight genetic counselors and study coordinators who provide support and explain results.
  3. Global Impact: Your de-identified data helps researchers worldwide, accelerating discoveries and improving understanding of GRI-related conditions.
  4. Sharing Data Insights: Simons Searchlight shares new summarized data findings with families and researchers through presentations, reports, and publications.

Ready to Make an Impact?

Your participation is a vital piece of long-term research that can drive future breakthroughs and benefit families for generations to come. Here is how you can get involved today:


Have Questions?
 Reach out directly to the Simons Searchlight Study Coordinators at Coordinator@SimonsSearchlight.org or visit simonssearchlight.org to learn more.

Read more posts

News

CureGRIN Awards $75K for Rare GRIN Disorder Research Grant

CureGRIN Foundation is pleased to announce an investment of $75,000 to cover the cost of functional analysis for 50 people with GRIN Disorder. The recipient of CureGRIN’s grant the Center for Functional Evaluation of Rare Variants (CFERV), led by Stephen Traynelis, PhD and Director. CFERV’s mission is to advance the scientific understanding of rare genetic variants that cause ultra-rare genetic conditions such as GRIN Disorder.